Most popular ETFs | ||||||
iShares Core MSCI World UCITS ETF USD (Acc) | IE00B4L5Y983 | Equity | ETF | |||
Xtrackers MSCI Emerging Markets UCITS ETF 1C | IE00BTJRMP35 | Equity | ETF | |||
Vanguard FTSE All-World UCITS ETF Distributing | IE00B3RBWM25 | Equity | ETF | |||
iShares Global Clean Energy UCITS ETF USD (Dist) | IE00B1XNHC34 | Equity | ETF | |||
HSBC FTSE 100 UCITS ETF GBP | IE00B42TW061 | Equity | ETF |
Most popular categories |
Equity, World |
Equity, Dividend strategy |
Bonds, UK Gilts |
Fund size | GBP 251 m |
Total expense ratio | 0.14% p.a. |
Replication | Synthetic (Unfunded swap) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 17.32% |
Inception/ Listing Date | 16 December 2009 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Invesco |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
Investment Advisor | Invesco Capital Management LLC |
Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
Revision Company | PricewaterhouseCoopers |
Fiscal Year End | 30 November |
Swiss representative | BNP Paribas, Paris, succursale de Zurich |
Swiss paying agent | BNP Paribas, Paris, succursale de Zurich |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | Goldman Sachs|Morgan Stanley|BofA Merrill Lynch|Nomura|J.P. Morgan |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
YTD | -4.75% |
1 month | +1.85% |
3 months | +3.77% |
6 months | +3.43% |
1 year | -1.12% |
3 years | +36.49% |
5 years | +61.84% |
Since inception (MAX) | +543.34% |
2022 | +9.47% |
2021 | +27.25% |
2020 | +9.30% |
2019 | +16.65% |
Volatility 1 year | 17.32% |
Volatility 3 years | 16.94% |
Volatility 5 years | 20.25% |
Return per risk 1 year | -0.06 |
Return per risk 3 years | 0.65 |
Return per risk 5 years | 0.50 |
Maximum drawdown 1 year | -15.23% |
Maximum drawdown 3 years | -15.23% |
Maximum drawdown 5 years | -19.80% |
Maximum drawdown since inception | -19.80% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | SML4 | - - | - - | - |
London Stock Exchange | GBX | XLVP | - - | - - | - |
Borsa Italiana | EUR | XLVS | XLVS IM XLVSIN | XLVS.MI XLVSINAV.DE | Commerzbank Banca IMI Flow Traders Susquehanna UniCredit |
London Stock Exchange | GBP | - | XLVP LN XLVSIN | XLVP.L XLVSINAV.DE | Commerzbank Banca IMI Flow Traders Susquehanna UniCredit |
London Stock Exchange | USD | XLVS | XLVS LN XLVSIN | XLVS.L XLVSINAV.DE | Commerzbank Banca IMI Flow Traders Susquehanna UniCredit |
SIX Swiss Exchange | USD | XLVS | XLVS SW XLVSIN | XLVS.S XLVSINAV.DE | Commerzbank Banca IMI Flow Traders Susquehanna UniCredit |
Fund name | Fund Size in m € (AuM) | TER in % p.a. | Distribution policy | Replication method |
---|---|---|---|---|
iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2,183 | 0.15% p.a. | Accumulating | Full replication |
Xtrackers MSCI USA Health Care UCITS ETF 1D | 879 | 0.12% p.a. | Distributing | Full replication |
Invesco Nasdaq Biotech UCITS ETF | 539 | 0.40% p.a. | Accumulating | Swap-based |
iShares Nasdaq US Biotechnology UCITS ETF | 369 | 0.35% p.a. | Accumulating | Sampling |
SPDR S&P US Health Care Select Sector UCITS ETF | 326 | 0.15% p.a. | Accumulating | Full replication |